Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-28T10:48:32.272Z Has data issue: false hasContentIssue false

Chapter 10 - Medication-induced tremors

Published online by Cambridge University Press:  05 July 2015

By
Peter A. LeWitt
Edited by
Joseph H. Friedman
Joseph H. Friedman
Affiliation:
Department of Neurology, Brown University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Medication-Induced Movement Disorders , pp. 104 - 109
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Elble, RJ. What is essential tremor? Curr Neurol Neurosci Rep 2013; 13:353. DOI 10.1007/s11910-013-0353-4.CrossRefGoogle ScholarPubMed
Borucki, MJ, Matzke, DS, Pollard, RB. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109: 77–78.CrossRefGoogle ScholarPubMed
Patterson, RG, Couchenour, RI. Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patient. Pharmacotherapy 1999; 19: 1456–1458.CrossRefGoogle Scholar
Conget, JI, Vendrell, J, Halperin, I, Esmatjes, E. Widespread tremor after injection of sodium calcitonin. Br Med J 1989; 298: 189.CrossRefGoogle ScholarPubMed
Brimblecombe, RW, Pinder, RM. Tremors and Tremorogenic Agents. Bristol (UK): Scientechnica, 1972.Google Scholar
LeWitt, PA. Tremor induced or enhanced by pharmacological means. In: Findley, L, Koller, WC (eds), Handbook of Tremor Disorders, New York: Marcel Dekker., Chap 34, pp 473–481, 1995.Google Scholar
Morgan, JC, Sethi, KD. Drug-induced tremors. Lancet Neurology 2005; 4:866–876.CrossRefGoogle ScholarPubMed
Micheli, F, Cerosimo, MG. Drug-induced parkinsonism. Handbook of Clinical Neurology. 2007; 84:399–416.CrossRefGoogle ScholarPubMed
Shin, H-W, Chung, SJ. Drug-induced parkinsonism. J Clin Neurol 2012; 8: 15–21.CrossRefGoogle ScholarPubMed
Boshes, RA, Oepen, G, Handren, M. Flapping tremor produced by high-potency neuroleptics. J Clin Psychopharmacol 1991: 11: 76–77.CrossRefGoogle ScholarPubMed
Friedman, JH. “Rubral” tremor induced by a neuroleptic drug. Mov Disord 1992; 42: 407–410.Google Scholar
Thomas, AA, Friedman, JH. Current use of clozapine in Parkinson disease and related disorders. Clin Neuropharmacol 2010; 33:14–16.CrossRefGoogle ScholarPubMed
Calne, DB, Webster, RA. Tremor induced by tetrabenazine. Br J Pharmacol 1969; 37: 468–475.CrossRefGoogle ScholarPubMed
Stacy, M, Jankovic, J. Tardive tremor. Mov Disord 1992; 7: 71–76.CrossRefGoogle ScholarPubMed
Shprecher, D. Sensory trick with metoclopramide-associated tardive tremor. Br Med J Case Rep 2012 pii:bcr1120115/156. Doi: 10.1136/bcr-11-2011-5156.CrossRefGoogle Scholar
Alonso-Navarro, H, Orti-Pareja, M, Jiménez-Jiménez, FJ et al. [Orthostatic tremor induced by pharmaceuticals]. Rev Neurol [in Spanish] 2004; 39: 834–836.Google ScholarPubMed
Hyman, NM, Dennis, PD, Sinclair, KG. Tremor due to sodium valproate. Neurology 1979; 29; 1177–1180.CrossRefGoogle ScholarPubMed
Karas, BJ, Wilder, BJ, Hammond, EJ, Bauman, AW. Valproate tremors. Neurology 1982; 32: 428–432.CrossRefGoogle ScholarPubMed
Rinnerthaler, M, Luef, G, Mueller, J, et al. Computerized tremor analysis of valproate induced tremor: a comparative study of controlled-release versus conventional valproate. Epilepsia 2005; 46: 320–323.CrossRefGoogle ScholarPubMed
Lancman, ME, Asconape, JJ, Walker, F. Acetazolamine appears effective in the management of valproate-induced tremor. Mov Disord 1994; 9:369.CrossRefGoogle Scholar
Kakisaka, Y, Ito, S, Ohara, T et al. Asymmetric drug-induced tremor: Rare feature of a common event. Pediatric Neurology 2013; 48: 479–480.CrossRefGoogle ScholarPubMed
Bech, P, Thomsen, J, Prytz, S et al. The profile and severity of lithium-induced side-effects in mentally healthy subjects. Neuropsychobiology 1979; 5: 160–166.CrossRefGoogle ScholarPubMed
Vestergaard, P, Poulstrup, I, Shou, M. Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 1988; 78: 434–441.CrossRefGoogle ScholarPubMed
Tyrer, P, Lee, I, Trotter, C. Physiologic characteristics of tremor after chronic lithium therapy. Br J Psychiatr 1981; 139: 851–853.CrossRefGoogle ScholarPubMed
Gelenberg, AJ, Jefferson, JW. Lithium tremor. J Clin Psychiatr 1995; 56: 283–287.Google ScholarPubMed
Donaldson, IM, Cunningham, J. Persisting neurological sequelae of lithium carbonate therapy. Arch Neurol 1983; 40: 747–751.CrossRefGoogle ScholarPubMed
Kronfol, Z, Greden, JF, Zis, AP. Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. J Clin Psychiatr 1983; 44:225–226.Google ScholarPubMed
Serrano-Duenas, M. Fluoxetine-induced tremor: clinical features in 21 patients. Parkinsonism Relat Disord 2002; 8: 325–327.CrossRefGoogle ScholarPubMed
Koller, W, Cone, S, Herbster, G. Caffeine and tremor. Neurology 1987;37):169–172.CrossRefGoogle ScholarPubMed
Seddon, P, Bara, A, Ducharme, FM, Lasserson, TJ. Oral xanthines as maintenance treatment for asthma in children. Cochrane Database Syst Rev 2006; (1):CD002885.Google Scholar
Cazzola, M, Matera, MG. Tremor and β(2)-adrenergic agents: is it a real clinical problem? Pulm Pharmacol Ther 2012; 25:4–10.CrossRefGoogle ScholarPubMed
Buss, DC, Marshall, RW, Milligan, N, et al. The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol 1997; 43:119–121.CrossRefGoogle ScholarPubMed
Palakurthy, PR, Iyer, V, Meckler, RJ. Unusual neurotoxicity associated with amiodarone therapy. Ann Intern Med 1987; 147: 881–884.CrossRefGoogle ScholarPubMed
Hilleman, D, Miller, MA, Parker, R et al. Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 1998; 18:138S–145S.CrossRefGoogle ScholarPubMed
Charness, ME, Morady, F, Scheinman, MM. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 1984; 34: 669–671.CrossRefGoogle ScholarPubMed
Coulter, DM, Edwards, IR, Savage, RI. Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme. N Z Med J 1990; 103: 98–100.Google ScholarPubMed
Werner, EG, Olanow, CW. Parkinsonism and amiodarone therapy. Ann Neurol 1989; 25:630–632.CrossRefGoogle ScholarPubMed
Peyrieux, JC, Boissel, JP, Leizorovicz, A. Relationship between plasma mexiletine levels at steady-state. Presence of ventricular arrhythmias and side effects. Fundam Clin Pharmacol 1987; 1:45–47.CrossRefGoogle ScholarPubMed
Manolis, AS, Deering, TF, Cameron, J, Estes, NA. Mexetiline: pharmacology and therapeutic use. Clin Cardiol 1990; 13:349–359.CrossRefGoogle ScholarPubMed
Rubenstein, A, Cabili, S. Tremor induced by procainamide. Am J Cardiol 1986; 57:340–341.CrossRefGoogle Scholar
Marti-Masso, JF, Pozo, JJ. Cinnizarine-induced parkinsonism: ten years later. Mov Disord 1998; 13: 453–456.CrossRefGoogle ScholarPubMed
Micheli, F, Fernandez-Pardal, M, Gatto, M et al. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 1987; 37:881–884.CrossRefGoogle ScholarPubMed
Dietz, AJ. Amphetamine-like reactions to phenylpropylamine. JAMA 1981; 245:439–442.CrossRefGoogle Scholar
Supiyaphun, P, Chochaipanichnon, I, Kerekhanjanarong, V, Saengpaniel, S. A comparative study of the side effects between pseudoephedrine in loratidine plus pseudoephedrine sulfate repetabs and loratidine + pseudoephedrine sulfate in treatment of allergic rhinitis in Thai patients. J Med Assoc Thai 2002; 85: 722–727.Google Scholar
Wade, JC, Meyers, JD. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med 1983; 98: 921–925.CrossRefGoogle ScholarPubMed
Rashiq, S, Briewa, L, Mooney, M, et al. Distinguishing acyclovir neurotoxicity from encephalomyelitis. J Intern Med 1993: 234: 507–511.CrossRefGoogle ScholarPubMed
Nadel, AM. Vidarabine therapy for herpes simplex encephalitis. The development of an unusual tremor during treatment. Arch Neurol 1981; 38: 384–385.CrossRefGoogle ScholarPubMed
Buedge, DR, Chow, AW, Sacks, SL. Neurotoxic effects during vidarabine therapy for herpes zoster. Can Med Assoc J 1985; 132: 392–395.Google Scholar
Kahan, DB, Flechner, SM, Lorber, MI et al. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for one to five years. Transplantation 1987; 43:197–204.CrossRefGoogle Scholar
Amery, WK, Heykants, J. Essential tremor and flunarizine. Cephalalgia 1988; 8:227.CrossRefGoogle ScholarPubMed
Capella, D, Laporte, JR, Castel, JM et al. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine. Brit Med J 1988; 297: 722–723.CrossRefGoogle ScholarPubMed
Koller, W, Orebaugh, C, Lawson, L, Potempa, K. Pindolol-induced tremor. Clin Neuropharmacol 1987; 10:449–452.CrossRefGoogle ScholarPubMed
Topaktas, S, Onur, R, Dalkara, T. Calcium channel blockers and essential tremor. Eur Neurol 1987; 27:114–119.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×